CompuMed, Inc.
CMPD · OTC
3/31/2025 | 12/31/2024 | 9/30/2024 | 6/30/2024 | |
|---|---|---|---|---|
| Revenue | $1,867 | $1,666 | $1,619 | $1,644 |
| % Growth | 12.1% | 2.9% | -1.6% | – |
| Cost of Goods Sold | $1,019 | $886 | $853 | $844 |
| Gross Profit | $848 | $780 | $766 | $800 |
| % Margin | 45.4% | 46.8% | 47.3% | 48.6% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $768 | $752 | $734 | $695 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $768 | $752 | $734 | $695 |
| Operating Income | $80 | $28 | $32 | $105 |
| % Margin | 4.3% | 1.7% | 1.9% | 6.4% |
| Other Income/Exp. Net | -$4 | -$5 | -$2 | -$1 |
| Pre-Tax Income | $76 | $23 | $30 | $104 |
| Tax Expense | $18 | $0 | $0 | $4 |
| Net Income | $59 | $23 | $30 | $101 |
| % Margin | 3.1% | 1.4% | 1.8% | 6.1% |
| EPS | 0.044 | 0.017 | 0.023 | 0.077 |
| % Growth | 158.1% | -24.2% | -70.4% | – |
| EPS Diluted | 0.044 | 0.017 | 0.023 | 0.077 |
| Weighted Avg Shares Out | 1,321 | 1,318 | 1,317 | 1,317 |
| Weighted Avg Shares Out Dil | 1,321 | 1,318 | 1,317 | 1,317 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $14 | $12 | $12 | $7 |
| Depreciation & Amortization | $207 | $174 | $177 | $173 |
| EBITDA | $298 | $208 | $219 | $285 |
| % Margin | 15.9% | 12.5% | 13.5% | 17.3% |